A randomized double blinded, 2 arm, multicenter, phase II study of ORA101 in combination with Cisplatin / Vinorelbine versus Cisplatin / Vinorelbine alone, in patients with advanced or recurrent non-small cell lung cancer, who have not received prior chemotherapy

Trial Profile

A randomized double blinded, 2 arm, multicenter, phase II study of ORA101 in combination with Cisplatin / Vinorelbine versus Cisplatin / Vinorelbine alone, in patients with advanced or recurrent non-small cell lung cancer, who have not received prior chemotherapy

Not stated
Phase of Trial: Phase II

Latest Information Update: 22 Feb 2007

At a glance

  • Drugs Cisplatin; Disulfiram; Vinorelbine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top